Human ether-a-go-go-related gene K+channels regulate shedding of leukemia cell-derived microvesicles
Authors:
- 13 March 2012
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 53 (8) , 1592-1598
Abstract
Microvesicles (MVs) are released by various cancer cells, including leukemia cells. They can “hijack” membrane components from their parental cells and exert pleiotropic effects on tumor progression. Human ether-a-go-go-related gene (hERG1) K + channels are highly expressed in cancer cells and appear of exceptional importance in favoring cancer development. Given the attributes of MVs and hERG1 K + channels in disease progression, we investigated the putative relationship between hERG1 K + channels and MVs in leukemia. The protein content of MVs isolated from K562 cell supernatants was significantly higher than that from HL-60 cells. The molecular profile of these MVs showed that in addition to the myeloid lineage antigen (CD11b), MVs contained hERG1 K + channels. Interestingly, inhibition of hERG1 K + channels rapidly reduced MV fractions in supernatants. Furthermore, MVs created positive feedback loops to facilitate leukemogenesis. Upon exposure to MVs, the plasma membrane expression of hERG1 protein was in turn up-regulated, the migration of leukemia cells was significantly increased, and the adhesion of leukemia cells to human umbilical vein endothelial cells (HUVECs) was markedly enhanced. Importantly, hERG1 K + channel inhibitor E-4031 impaired these effects. We conclude that leukemia cell-derived MVs can “hijack” the plasma membrane hERG1 K + channels, which regulate the release of MVs and their biological effects upon leukemia cells.Keywords
This publication has 30 references indexed in Scilit:
- Microvesicles: mediators of extracellular communication during cancer progressionJournal of Cell Science, 2010
- Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progressionBlood, 2010
- Microvesicles: Messengers and mediators of tumor progressionCell Cycle, 2009
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cellsLeukemia, 2009
- Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumorsInternational Journal of Cancer, 2009
- Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 AxisCancer Research, 2009
- Senescence-Associated Exosome Release from Human Prostate Cancer CellsCancer Research, 2008
- Expression and Role of hERG Channels in Cancer Cells2005
- Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasmsJournal of Clinical Pathology, 2004
- Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cellsExperimental Hematology, 2002